Central nervous system tuberculoma can have variable presentations depending on the site and number of tuberculomas. We are reporting a rare case of an 11-year-old male child presenting with ptosis and ataxia. Clinical examination revealed bilateral partial 3 rd cranial nerve palsy (ptosis without any upward gaze palsy) associated with dysdiadochokinesia and ataxia on the right side. Magnetic resonance imaging of the brain revealed a single ring-enhancing lesion in the dorsal midbrain with perifocal edema. Magnetic resonance spectroscopy provided the etiological information as tuberculoma.
Introduction
Tuberculosis (TB) is still an important public health problem in the developing countries with constant endemicity. It accounts for about 40% of all the intracranial space-occupying lesions (SOLs). Isolated brainstem tuberculoma is a comparatively rare entity with only 5-10% incidence among them. [1, 2] Here, we report a case of an 11-year-old male child presenting with bilateral ptosis and right-sided ataxia, ultimately diagnosed to have midbrain tuberculoma by magnetic resonance spectroscopy (MRS).
Case Report
An 11-year-old male child presented with a history of drooping of both the eyelids for 5 days with associated headache and ataxia for 2 days. He had no history of fever, convulsion, or loss of vision. There was a history of contact with a case of TB in the neighborhood. Clinical examination revealed bilateral symmetrical ptosis [ Figure 1 ], but the movement of both the eyeballs was normal in all the directions with normal pupillary size and reaction bilaterally. Other cranial nerves were essentially normal. Dysdiadochokinesia and ataxia were noted on the right side. No weakness was found in any of the limbs. Deep tendon jerks were bilaterally normal with a normal plantar response.
Investigations revealed normal blood counts and raised erythrocyte sedimentation rate. Mantoux test was negative and chest radiograph was normal. Magnetic resonance imaging (MRI) of the brain revealed single ring-like enhancing lesion in the dorsal part of the midbrain with significant perifocal edema in adjacent parts of the brainstem, right cerebellar peduncle, adjacent thalamocortical tract, and periventricular region [ Figure 2 ]. MRS at the site of the lesion showed increased lipid peak, decreased N-acetylaspartate (NAA) peak with increased choline/creatinine ratio, suggestive of tuberculoma [ Figure 3 ].
He was started on four drugs antitubercular treatment (ATT) (isoniazid [10 mg/kg/day], rifampicin [10 mg/kg/day], ethambutol [25 mg/kg/day], and pyrazinamide [35 mg/kg/day] -all thrice a week) along with intravenous dexamethasone (0.6 mg/kg/day in 4 divided doses). Later, dexamethasone was switched over to oral prednisolone at 1 mg/kg/day which was tapered after 6 weeks. Ataxia and headache responded within 2 days of starting the treatment, whereas drooping of eyelids improved gradually after 4 weeks of treatment. No worsening of symptoms was noted. ATT was continued for 12 months (2 months intensive phase with four drugs, followed by 10 months continuation phase with isoniazid and rifampicin) and the child is doing well without any symptom at 12 and 18 months follow-up.
Discussion
Neurotuberculosis comprises 5-15% cases of extrapulmonary TB. Common locations of intracranial tuberculoma are cerebral and cerebellar hemispheres due to their rich blood supply. Other rare locations include quadrigeminal cistern, cerebellopontine angle, and suprasellar region. [3] Isolated brainstem tuberculomas are also rare with varied clinical presentations depending on the number and site of lesion and associated edema. Kumar et al. reported a patient presenting as isolated bilateral ptosis due to midbrain tuberculoma. [4] The other presentations of brainstem tuberculoma mentioned in literature were pontine tuberculoma with horizontal gaze palsy, [5] bilateral internuclear ophthalmoplegia, [6] one-and-a-half syndrome, [7] and eight-and-a-half syndrome. [8] The nucleus of the oculomotor nerve does not consist of a continuous column of cells, but is broken up into a number of smaller nuclei, which are arranged in two groups, anterior and posterior. Those of the posterior group are six in number, five of which are symmetrical on two sides of the midline, while the sixth is centrally placed and is common to the nerves of both sides. The anterior group consists of two nuclei, an anteromedial and an anterolateral. The central caudate subnucleus is single and controls both levators. The autonomic nucleus (Edinger-Westphal) is single at one end and divided into two horns at its anterior end. A few scattered large multipolar cells are seen on the midline raphe between the right and left oculomotor masses. They innervate the superior recti muscles, rather than the medial recti. It should be noted, however, that it is more common to find ptosis in association with upgaze paresis as the unpaired superior rectus subnuclei are located medially in close relation to the caudal central subnucleus (i.e., levator palpebrae subnucleus).
The critical location of the lesion in the right dorsal midbrain with perilesional edema in our patient explains the clinical manifestations of 3 rd cranial nerve palsy and cerebellar involvement. However, the occurrence of partial 3 rd cranial nerve palsy (i.e., ptosis without affection of the upward gaze) could have been due to the isolated involvement of caudal central subnucleus without affecting the fibers innervating superior recti muscle.
According to the clinical picture, which suggests the topography to be midbrain and cerebellum, differential diagnoses should be the causes of childhood stroke (such as hemorrhage or infarction, notably lacunar infarcts) or any other SOL, such as brain tumor, abscess, tuberculoma, and neurocysticercosis (NCC). Lacunar infarcts presenting with atypical lacunar syndromes include bilateral paramedian thalamic lacunar infarct, [9] which can have a similar presentation clinically and, thus, should be considered as a differential diagnosis. However, the presentation here is more subacute compared to the acute stroke syndrome and MRI brain excludes the possibility by clearly showing a ring-enhancing lesion.
Now, differentiation among the ring-enhancing SOLs necessitates the use of MRS. Gliomas, metastases, abscesses, NCC, and demyelinating diseases were the differential diagnoses that were considered in our patient and MRS is considered diagnostic to exclude the differentials. MRS may increase the specificity of diagnosis by identifying lipids within the lesions that are considered characteristic for TB. In vivo and in vitro MRS has shown elevated lipid peaks within the TB lesions. [10] The other findings are decreased NAA peak and increased choline/creatinine ratio. Whereas choline/creatinine ratio is comparatively lower in NCC, demyelinating lesions may show glutamine/glutamate peak along with raised choline and low NAA, abscesses show absent NAA inside the lesion, and brain tumors have high lactate along with other routine findings. Hence, characteristic MRS findings and, finally, response to ATT supported the diagnosis of tuberculoma in our case.
This case highlights the rarity of midbrain tuberculoma and its unique presentation as isolated nuclear oculomotor nerve palsy with cerebellar involvement. It also justifies the importance of realizing the architectural organization of oculomotor nerve fibers responsible for its varying clinical presentations. To the best of our knowledge, ataxia with bilateral ptosis without any gaze palsy due to midbrain tuberculoma has not been previously reported.
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TB remains among the leading causes of morbidity and mortality with CNS involvement occurring in up to 5% of patients. [2] In endemic regions, CNS tuberculomas comprise up to 30% of all intracranial mass lesions. Therefore, CNS tuberculoma should be included in the differential diagnosis in anyone presenting with intracranial mass lesion with or without TB risk factors. However, the diagnosis of CNS tuberculoma can be difficult if based solely on clinical presentation and routinely available imaging methods. For example, tuberculin skin test and chest radiographic are often negative and should not be used to rule out CNS TB. Routine brain imaging modalities, such as computed tomography (CT) and magnetic resonance imaging, usually demonstrate nonspecific findings that are similar to other CNS infections, CNS lymphoma, and brain metastases. [3] A constantly increasing body of evidence suggests that 1 H-MRS can be valuable noninvasive imaging tool with high diagnostic yield for CNS tuberculoma. Elevated lipid peak is the most specific 1 H-MRS findings for CNS tuberculoma because cell wall of mycobacteria is predominantly composed of lipids. For example, Santy et al. demonstrated lipid peak on 1 H-MRS in four pediatric patients presenting with presumable CNS tuberculoma. [4] However, infection with Mycobacterium tuberculosis was not confirmed by the means of culture or molecular methods in the latter study. Another study from Peru in patients presenting with single enhancing brain lesions demonstrated that 1 H-MRS reliably distinguished between CNS tuberculoma and neurocysticercosis, with tuberculomas demonstrating high lipid peak, more choline, and less N-acetylaspartate and creatine. [5] However, another study for China that included 19 patients with intracranial tuberculomas and 22 patients with high-grade gliomas (HGGs) found significantly lower choline/creatinine and choline/ N-acetylaspartate ratio in CNS tuberculomas relative to HGGs, while lesion-to-normal brain lipid ratio was similar between the two patient groups. [6] These findings suggest that 1 H-MRS is a promising diagnostic tool for CNS tuberculoma that provides with pathogenically specific biochemical information for M. tuberculosis infection. However, further research in larger patient populations validating the clinical utility of 1 H-MRS for differentiating CNS tuberculoma from other ring enhancing mass lesions should be performed. There should be efforts to combine currently existing raw 1 H-MRS data from smaller case series and case reports into a larger dataset to identify 1 H-MRS fingerprints of CNS tuberculoma.
Albeit 1 H-MRS is becoming increasingly used for diagnosis and treatment guidance of CNS tuberculoma patients, but it should be recalled that definitive diagnosis of TB requires isolation of M. tuberculosis or positive acid-fast stain in tissue biopsy. [2] The major advantages of definite tissue diagnosis are expedited initiation of effective treatment interventions and avoidance of side effects associated with potentially ineffective empirical therapy. Furthermore, due to a high prevalence rate of drug resistance, universal drug susceptibility testing of M. tuberculosis is strongly recommended by the World Health Organization. [1] It is estimated that 3.3% of new TB cases are multidrug-resistant TB (MDR-TB), and of these, 9.7% of patients have extensively drug-resistant TB defined as MDR-TB plus resistance to at least one fluoroquinolone and a second-line injectable medication. [2] Therefore, drug susceptibility of M. tuberculosis should be considered when choosing treatment regimen.
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